![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://pbs.twimg.com/media/HHFQZHUbgAAcwgn.jpg)
eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for
USD27.80
USD75.80
Pay in 4 interest-free payments of $6.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3864614363235387532)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://media.licdn.com/dms/image/v2/D5603AQFP1wvEbMH4Rg/profile-displayphoto-scale_400_400/B56ZfgDr.mHEAg-/0/1751810753013?e=2147483647&v=beta&t=0KgEmS1zGISO2ACnPUJJy5Xe4GIpf_3VMFoAmUP0FZE)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://substackcdn.com/image/fetch/$s_!q2fE!,f_auto,q_auto:best,fl_progressive:steep/https%3A%2F%2Ferictopol.substack.com%2Fapi%2Fv1%2Fpost_preview%2F138773822%2Ftwitter.jpg%3Fversion%3D4)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://static.scientificamerican.com/dam/asset/f2a96b00-375c-442c-b488-82bfb96cf27c/GLP-1-drugs.jpg?m=1782073276.875&w=1200)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case GLP-1 drugs aren't just for](https://substackcdn.com/image/fetch/$s_!KYTy!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F3eb691b5-c9c4-4a78-8ef8-b9d6e502ef35_600x842.png)
